Hepion Pharmaceuticals, Inc.
HEPA
$0.06
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.79M | 3.32M | 4.50M | 5.67M | 6.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.28M | 3.76M | 4.35M | 8.28M | 15.44M |
| Operating Income | -3.28M | -3.76M | -4.35M | -8.28M | -15.44M |
| Income Before Tax | -2.98M | -8.28M | -9.17M | -13.56M | -16.44M |
| Income Tax Expenses | -- | -- | 0.00 | 0.00 | 0.00 |
| Earnings from Continuing Operations | -2.98 | -8.28 | -9.17 | -13.56 | -16.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.98M | -8.28M | -9.17M | -13.56M | -16.44M |
| EBIT | -3.28M | -3.76M | -4.35M | -8.28M | -15.44M |
| EBITDA | -2.46M | -3.73M | -4.33M | -8.27M | -15.44M |
| EPS Basic | -0.26 | -2.34 | -13.39 | -49.56 | -83.31 |
| Normalized Basic EPS | -0.18 | -1.48 | -13.20 | -36.11 | -81.60 |
| EPS Diluted | -0.26 | -2.34 | -13.39 | -49.56 | -83.31 |
| Normalized Diluted EPS | -0.18 | -1.48 | -13.20 | -36.11 | -81.60 |
| Average Basic Shares Outstanding | 46.25M | 37.46M | 25.92M | 14.44M | 3.23M |
| Average Diluted Shares Outstanding | 46.25M | 37.46M | 25.92M | 14.44M | 3.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |